ArticleClinical parkinsonism & related disorders2022
Change in the Parkinson Anxiety Scale correlates with change in other clinical measures of anxiety over time.
Article in Clinical parkinsonism & related disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05335850 (Meditation and Breathing for Mental Health in Parkinson's Disease Patient), which is not on this map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Meditation and Breathing for Mental Health in Parkinson's Disease Patient
Who cites it
4 citing papers in PubMed, 3 citations in OpenAlex.
- High HAM-A-Detected Prevalence of Anxiety in Parkinson's Disease, but No Correlation with Severity of Motor Disease.Diseases (Basel, Switzerland) · 2026Article
- Meditation and breathwork on anxiety in Parkinson's disease: A pilot randomized controlled trial.Journal of Parkinson's disease · 2026Article
- Validation of the English version of the Parkinson Anxiety Scale in two Canadian Parkinson's disease samples.Clinical parkinsonism & related disorders · 2025Article
- Motor cortico-nigral and cortico-entopeduncular information transmission and its modulation by buspirone in control and after dopaminergic denervation.Frontiers in pharmacology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Parkinson's disease (PD)-specific Parkinson Anxiety Scale (PAS) is an anxiety rating scale that has been validated in cross-sectional studies. In a study of buspirone for anxiety in PD, it appears that the PAS may be sensitive to change in anxiety demonstrating moderate-to-high correlation with participant-reported and clinician-administered scales.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.